Pleural Disease Therapeutics Market to reach US$ 9.4 billion in 2033, Thoracentesis based Treatment to account for 34% Revenue: FMI

A recently published study by Future Market Insights, the global pleural disease therapeutics market is expected to accumulate a valuation of US$ 9.4 billion by 2033, registering a CAGR of 6.5% across the forthcoming decade. Increasing prevalence of congestive heart failure, and other heart conditions, lung conditions, pneumonia, cancer and tuberculosis is estimated to propel …

Global Optic Atrophy Management Market to surpass US$ 15 billion by 2033, growing at a 4.9% CAGR: FMI Study

According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are …

Healthcare Providers Boost the Sales of Point-of-care Molecular Diagnostics due to its Quick Results on Patients’ Healthcare Conditions. Track More Opportunities with FMI Intelligence

The point-of-care molecular diagnostics market is predicted to secure a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …

The Necessity for High-quality Goods, as well as Improving Living Standards, Play a Key Role in the Cleanroom Technologies Market Expansion, FMI records a CAGR of 6.2% from 2023 to 2033.

The cleanroom technology market is expected to be worth around US$ 13.9 billion by 2033, up from US$ 7.6 billion in 2023. The increased demand for quality products that meet regulatory standards, together with the technological and economic benefits of these technologies, is assisting enterprises to achieve higher rankings. Furthermore, benefits such as tailored solutions, …

Medical Disposables Market to be worth US$ 326 Billion by 2033, Reveals Future Market Insights

The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326 Billion. Bandages and Wound Dressings commanded the largest …

Takotsubo Syndrome Therapeutics Market is expected to reach US$ 2.85 Billion in 2033

The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as …

Peptide Drug Conjugates Market is projected to expand at a 20% CAGR through 2033

The global peptide drug conjugates market is anticipated to hold a market value of US$ 861.12 Million in 2023 and US$ 5,331.83 Million by 2033. The projected growth rate is nearly 20% during the forecast period from 2023 to 2033. The growth of the market is attributed to the global upsurge in cancer cases and …

Chronic Wound Care Market is expected to expand at a 7% value CAGR by 2033

According to Future Market Insights, chronic wound care are expected to grow at a CAGR of 7% between 2023 and 2033, reaching US$ 31.46 Billion in 2033. Sales grew at a CAGR of 6.5% from 2018 to 2023. New innovative products are expected to be introduced to the market as a result of growing research …

Pelvic Cancer Induced Hemorrhegic Cystitis Market is projected to reach US$ 11 Billion by 2033

The global pelvic cancer induced hemorrhegic cystitis market size is expected to surpass an impressive valuation of US$ 2.1 Billion in 2023 and is projected to reach US$ 11 Billion by 2033, with a CAGR of 18.01%, as per a recently published research by Future Market Insights. Rising awareness among the population regarding early treatment …

Vernal Keratoconjunctivitis Market is expected to grow with a 6% CAGR during 2023 to 2033

The global Vernal Keratoconjunctivitis market is expected to garner a market value of US$ 436.9 Million in 2023 and is expected to accumulate a market value of US$ 782.42 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. One of the reasons driving the global market over the projection period …